Table of Contents Author Guidelines Submit a Manuscript
BioMed Research International
Volume 2017, Article ID 3809464, 10 pages
https://doi.org/10.1155/2017/3809464
Research Article

Combined Detection of Preoperative Neutrophil-to-Lymphocyte Ratio and CEA as an Independent Prognostic Factor in Nonmetastatic Patients Undergoing Colorectal Cancer Resection Is Superior to NLR or CEA Alone

1Department of General Surgery, The Second Affiliated Hospital, Zhejiang University College of Medicine, Hangzhou 310009, China
2Department of Laboratory Medicine, Changhai Hospital, 168 Changhai Road, Shanghai 200433, China
3Department of General Surgery, Changhai Hospital, 168 Changhai Road, Shanghai 200433, China
4Department of Medical Oncology, The Second Affiliated Hospital, Zhejiang University College of Medicine, Hangzhou 310009, China

Correspondence should be addressed to Kefeng Ding; nc.ude.ujz@gnefekgnid

Received 9 December 2016; Accepted 12 February 2017; Published 8 June 2017

Academic Editor: Xin-yuan Guan

Copyright © 2017 Xiaoli Zhan et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. A. Jemal, F. Bray, M. M. Center, J. Ferlay, E. Ward, and D. Forman, “Global cancer statistics,” CA Cancer Journal for Clinicians, vol. 61, no. 2, pp. 69–90, 2011. View at Publisher · View at Google Scholar · View at Scopus
  2. P.-L. Tsai, W.-J. Su, W.-H. Leung, C.-T. Lai, and C.-K. Liu, “Neutrophil-lymphocyte ratio and CEA level as prognostic and predictive factors in colorectal cancer: a systematic review and meta-analysis,” Journal of Cancer Research and Therapeutics, vol. 12, no. 2, pp. 582–589, 2016. View at Publisher · View at Google Scholar · View at Scopus
  3. D. I. Obrand and P. H. Gordon, “Incidence and patterns of recurrence following curative resection for colorectal carcinoma,” Diseases of the Colon and Rectum, vol. 40, no. 1, pp. 15–24, 1997. View at Publisher · View at Google Scholar · View at Scopus
  4. H.-L. Rao, J.-W. Chen, M. Li et al., “Increased intratumoral neutrophil in colorectal carcinomas correlates closely with malignant phenotype and predicts patients' adverse prognosis,” PLoS ONE, vol. 7, no. 1, pp. e30806–e30814, 2012. View at Publisher · View at Google Scholar · View at Scopus
  5. H. Kubo, Y. Murayama, T. Arita, Y. Kuriu, M. Nakanishi, and E. Otsuji, “The prognostic value of preoperative neutrophil-to-lymphocyte ratio in colorectal cancer,” World Journal of Surgery, vol. 40, no. 11, pp. 2796–2802, 2016. View at Publisher · View at Google Scholar · View at Scopus
  6. Y. Zhang, G. Zhou, X. Liu et al., “Exploration and validation of C-reactive protein/albumin ratio as a novel inflammation-based prognostic marker in nasopharyngeal carcinoma,” Journal of Cancer, vol. 7, no. 11, pp. 1406–1412, 2016. View at Publisher · View at Google Scholar
  7. J. Szkandera, M. Pichler, G. Absenger et al., “The elevated preoperative platelet to lymphocyte ratio predicts decreased time to recurrence in colon cancer patients,” American Journal of Surgery, vol. 208, no. 2, pp. 210–214, 2014. View at Publisher · View at Google Scholar · View at Scopus
  8. M. Mahsuni Sevinc, U. Riza Gunduz, and E. Kinaci, “Preoperative neutrophil-to-lymphocyte ratio and plateletto-lymphocyte ratio as new prognostic factors for patients with colorectal cancer,” Journal of BUON, vol. 21, no. 5, pp. 1153–1157, 2016. View at Google Scholar
  9. Y. Maeda, T. Kawahara, M. Koizumi et al., “Lack of an association between neutrophil-to-lymphocyte ratio and PSA failure of prostate cancer patients who underwent radical prostatectomy,” BioMed Research International, vol. 2016, Article ID 6197353, 6 pages, 2016. View at Publisher · View at Google Scholar · View at Scopus
  10. J. Huang, D. M. Dahl, L. Dong et al., “Preoperative neutrophil-to-lymphocyte ratio and neutrophilia are independent predictors of recurrence in patients with localized papillary renal cell carcinoma,” BioMed Research International, vol. 2015, Article ID 891045, 2015. View at Publisher · View at Google Scholar · View at Scopus
  11. S. Ohtake, T. Kawahara, R. Kasahara et al., “Pretreatment neutrophil-to-lymphocyte ratio can predict the prognosis in bladder cancer patients who receive gemcitabine and nedaplatin therapy,” BioMed Research International, vol. 2016, Article ID 9846823, 5 pages, 2016. View at Publisher · View at Google Scholar
  12. S.-S. Byun, E. C. Hwang, S. H. Kang et al., “Prognostic significance of preoperative neutrophil-to-lymphocyte ratio in nonmetastatic renal cell carcinoma: a large, multicenter cohort analysis,” BioMed Research International, vol. 2016, Article ID 5634148, 8 pages, 2016. View at Publisher · View at Google Scholar
  13. G. Malietzis, M. Giacometti, A. Askari et al., “A preoperative neutrophil to lymphocyte ratio of 3 predicts disease-free survival after curative elective colorectal cancer surgery,” Annals of Surgery, vol. 260, no. 2, pp. 287–292, 2014. View at Publisher · View at Google Scholar · View at Scopus
  14. W. Chua, K. A. Charles, V. E. Baracos, and S. J. Clarke, “Neutrophil/lymphocyte ratio predicts chemotherapy outcomes in patients with advanced colorectal cancer,” British Journal of Cancer, vol. 104, no. 8, pp. 1288–1295, 2011. View at Publisher · View at Google Scholar · View at Scopus
  15. H.-Y. Hung, J.-S. Chen, C. Y. Yeh et al., “Effect of preoperative neutrophil-lymphocyte ratio on the surgical outcomes of stage II colon cancer patients who do not receive adjuvant chemotherapy,” International Journal of Colorectal Disease, vol. 26, no. 8, pp. 1059–1065, 2011. View at Publisher · View at Google Scholar · View at Scopus
  16. S. Mallappa, A. Sinha, S. Gupta, and S. J. D. Chadwick, “Preoperative neutrophil to lymphocyte ratio >5 is a prognostic factor for recurrent colorectal cancer,” Colorectal Disease, vol. 15, no. 3, pp. 323–328, 2013. View at Publisher · View at Google Scholar · View at Scopus
  17. R. Carruthers, L. M. Tho, J. Brown, S. Kakumanu, E. Mccartney, and A. C. Mcdonald, “Systemic inflammatory response is a predictor of outcome in patients undergoing preoperative chemoradiation for locally advanced rectal cancer,” Colorectal Disease, vol. 14, no. 10, pp. e701–e707, 2012. View at Publisher · View at Google Scholar · View at Scopus
  18. K. Neofytou, E. C. Smyth, A. Giakoustidis et al., “The preoperative lymphocyte-to-monocyte ratio is prognostic of clinical outcomes for patients with liver-only colorectal metastases in the neoadjuvant setting,” Annals of Surgical Oncology, vol. 22, no. 13, pp. 4353–4362, 2015. View at Publisher · View at Google Scholar · View at Scopus
  19. J. Budczies, F. Klauschen, B. V. Sinn et al., “Cutoff Finder: a comprehensive and straightforward web application enabling rapid biomarker cutoff optimization,” PLoS ONE, vol. 7, no. 12, pp. e51862–e51869, 2012. View at Publisher · View at Google Scholar · View at Scopus
  20. M. Shibutani, K. Maeda, H. Nagahara et al., “A high preoperative neutrophil-to-lymphocyte ratio is associated with poor survival in patients with colorectal cancer,” Anticancer Research, vol. 33, no. 8, pp. 3291–3294, 2013. View at Google Scholar · View at Scopus
  21. K. Neofytou, E. C. Smyth, A. Giakoustidis, A. Z. Khan, D. Cunningham, and S. Mudan, “Elevated platelet to lymphocyte ratio predicts poor prognosis after hepatectomy for liver-only colorectal metastases, and it is superior to neutrophil to lymphocyte ratio as an adverse prognostic factor,” Medical Oncology, vol. 31, no. 10, pp. 239–247, 2014. View at Publisher · View at Google Scholar · View at Scopus
  22. M. Yao, Y. Liu, H. Jin et al., “Prognostic value of preoperative inflammatory markers in Chinese patients with breast cancer,” OncoTargets and Therapy, vol. 7, pp. 1743–1752, 2014. View at Publisher · View at Google Scholar · View at Scopus
  23. J. S. Shin, K. W. Suh, and S. Y. Oh, “Preoperative neutrophil to lymphocyte ratio predicts survival in patients with T1-2N0 colorectal cancer,” Journal of Surgical Oncology, vol. 112, no. 6, pp. 654–657, 2015. View at Publisher · View at Google Scholar · View at Scopus
  24. T. Kubo, S. Ono, H. Ueno, E. Shinto, J. Yamamoto, and K. Hase, “Impact of the perioperative neutrophil-to-lymphocyte ratio on the long-term survival following an elective resection of colorectal carcinoma,” International Journal of Colorectal Disease, vol. 29, no. 9, pp. 1091–1099, 2014. View at Publisher · View at Google Scholar · View at Scopus
  25. S. Tohme, D. Sukato, D. Chalhoub et al., “Neutrophil-lymphocyte ratio is a simple and novel biomarker for prediction of survival after radioembolization for metastatic colorectal cancer,” Annals of Surgical Oncology, vol. 22, no. 5, pp. 1701–1707, 2015. View at Publisher · View at Google Scholar · View at Scopus
  26. M. M. Remedi, A. C. Donadio, and G. A. Chiabrando, “Polymorphonuclear cells stimulate the migration and metastatic potential of rat sarcoma cells,” International Journal of Experimental Pathology, vol. 90, no. 1, pp. 44–51, 2009. View at Publisher · View at Google Scholar · View at Scopus
  27. S. Tazzyman, C. E. Lewis, and C. Murdoch, “Neutrophils: key mediators of tumour angiogenesis,” International Journal of Experimental Pathology, vol. 90, no. 3, pp. 222–231, 2009. View at Publisher · View at Google Scholar · View at Scopus
  28. A. D. Gregory and A. M. Houghton, “Tumor-associated neutrophils: new targets for cancer therapy,” Cancer Research, vol. 71, no. 7, pp. 2411–2416, 2011. View at Publisher · View at Google Scholar · View at Scopus
  29. E. B. Eruslanov, P. S. Bhojnagarwala, J. G. Quatromoni et al., “Tumor-associated neutrophils stimulate T cell responses in early-stage human lung cancer,” Journal of Clinical Investigation, vol. 124, no. 12, pp. 5466–5480, 2014. View at Publisher · View at Google Scholar · View at Scopus
  30. M. Kaneko, H. Nozawa, K. Sasaki et al., “Elevated neutrophil to lymphocyte ratio predicts poor prognosis in advanced colorectal cancer patients receiving oxaliplatin-based chemotherapy,” Oncology, vol. 82, no. 5, pp. 261–268, 2012. View at Publisher · View at Google Scholar · View at Scopus
  31. Y. Toiyama, Y. Inoue, S. Saigusa et al., “C-Reactive protein as predictor of recurrence in patients with rectal cancer undergoing chemoradiotherapy followed by surgery,” Anticancer Research, vol. 33, no. 11, pp. 5065–5074, 2013. View at Google Scholar · View at Scopus
  32. R. A. Graham, S. Wang, P. J. Catalano, and D. G. Haller, “Postsurgical surveillance of colon cancer: preliminary cost analysis of physician examination, carcinoembryonic antigen testing, chest x-ray, and colonoscopy,” Annals of Surgery, vol. 228, no. 1, pp. 59–63, 1998. View at Publisher · View at Google Scholar · View at Scopus
  33. P. Thirunavukarasu, S. Sukumar, M. Sathaiah et al., “C-stage in colon cancer: implications of carcinoembryonic antigen biomarker in staging, prognosis, and management,” Journal of the National Cancer Institute, vol. 103, no. 8, pp. 689–697, 2011. View at Publisher · View at Google Scholar · View at Scopus
  34. M. J. Goldstein and E. P. Mitchell, “Carcinoembryonic antigen in the staging and follow-up of patients with colorectal cancer,” Cancer Investigation, vol. 23, no. 4, pp. 338–351, 2005. View at Publisher · View at Google Scholar · View at Scopus
  35. H. J. Schmoll, E. Van cutsem, A. Stein et al., “Esmo consensus guidelines for management of patients with colon and rectal cancer. A personalized approach to clinical decision making,” Annals of Oncology, vol. 23, no. 10, pp. 2479–2516, 2012. View at Publisher · View at Google Scholar · View at Scopus
  36. H.-C. Kwon, S. H. Kim, S. Y. Oh et al., “Clinical significance of preoperative neutrophil-lymphocyte versus platelet-lymphocyte ratio in patients with operable colorectal cancer,” Biomarkers, vol. 17, no. 3, pp. 216–222, 2012. View at Publisher · View at Google Scholar · View at Scopus
  37. V. Wiwanitkit, “NLR as predictor: a concern in laboratory medicine aspect,” International Journal of Colorectal Disease, vol. 26, no. 11, p. 1499, 2011. View at Publisher · View at Google Scholar · View at Scopus
  38. D. C. McMillan, “The systemic inflammation-based Glasgow Prognostic Score: a decade of experience in patients with cancer,” Cancer Treatment Reviews, vol. 39, no. 5, pp. 534–540, 2013. View at Publisher · View at Google Scholar · View at Scopus
  39. T. C. Chua, C. H. Chong, W. Liauw, J. Zhao, and D. L. Morris, “Inflammatory markers in blood and serum tumor markers predict survival in patients with epithelial appendiceal neoplasms undergoing surgical cytoreduction and intraperitoneal chemotherapy,” Annals of Surgery, vol. 256, no. 2, pp. 342–349, 2012. View at Publisher · View at Google Scholar · View at Scopus
  40. W. He, C. Yin, G. Guo et al., “Initial neutrophil lymphocyte ratio is superior to platelet lymphocyte ratio as an adverse prognostic and predictive factor in metastatic colorectal cancer,” Medical Oncology, vol. 30, no. 1, pp. 439–444, 2013. View at Publisher · View at Google Scholar · View at Scopus